Skip to main content

Table 1 Patient characteristics

From: Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes

 

Patients (n = 122)

Controls (n = 58)

Age (years)

62 (37–86)

62 (43–81)

Sex (female)

60 (49%)

31 (53%)

ISS stage

 I

33 (27%)

 

 II

47 (39%)

 

 III

28 (23%)

 

 Unknown

14 (11%)

 

M-component

 IgG

75 (61%)

 

 IgA

29 (24%)

 

 Light chain

6 (5%)

 

 Unknown

12 (10%)

 

Skeletal affection

 None

12 (10%)

 

 Limited

49 (40%)

 

 Osteoporosis

9 (7%)

 

 Advanced

48 (39%)

 

 Unknown

4 (3%)